A detailed history of Simplex Trading, LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 3,400 shares of MORF stock, worth $115,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,400
Previous 187 1718.18%
Holding current value
$115,838
Previous $5,000 2280.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$26.64 - $40.31 $85,594 - $129,516
3,213 Added 1718.18%
3,400 $119,000
Q4 2023

Feb 02, 2024

BUY
$19.95 - $31.0 $3,730 - $5,797
187 New
187 $5,000
Q2 2023

Aug 04, 2023

BUY
$34.33 - $62.11 $30,656 - $55,464
893 Added 4.69%
19,919 $1.14 Million
Q1 2023

Apr 27, 2023

BUY
$26.01 - $48.69 $494,866 - $926,375
19,026 New
19,026 $716,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.